DIAGNOSIS AND THERAPY OF THE HEMOSTATIC SYSTEM DISORDERS IN LIVER TRANSPLANTATION
https://doi.org/10.23873/2074-0506-2017-9-3-252-255
About the Authors
S. V. Zhuravel'Russian Federation
Sergey V. Zhuravel' (Speaker) - Dr. Med. Sci., Head of the Research Department of Anesthesiology and Resuscitation for Organ Transplants.
Moscow
I. I. Utkina
Russian Federation
Moscow
N. S. Zhuravel'
Russian Federation
Moscow
N. K. Kuznetsova
Russian Federation
Moscow
References
1. Englesbe M.J., Kubus J., Muhammad W., et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Trans. 2010;16(1):83–90. DOI:10.1002/lt.21941.
2. Afdhal N.H., Giannini E.G., Tayyab G., et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012;367(8):716–724. DOI:10.1056/NEJMoa1110709.
3. Zocco M.A., Di Stasio E., De Cristofaro R., et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51(4):682–689. DOI:10.1016/j.jhep.2009.03.013.
Review
For citations:
Zhuravel' S.V., Utkina I.I., Zhuravel' N.S., Kuznetsova N.K. DIAGNOSIS AND THERAPY OF THE HEMOSTATIC SYSTEM DISORDERS IN LIVER TRANSPLANTATION. Transplantologiya. The Russian Journal of Transplantation. 2017;9(3):252-255. (In Russ.) https://doi.org/10.23873/2074-0506-2017-9-3-252-255